Literature DB >> 24903164

Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.

Christina C Marasco1, Cody R Goodwin2, Danny G Winder3, Nicole L Schramm-Sapyta4, John A McLean2, John P Wikswo5.   

Abstract

The human body is a complex assembly of physiological systems designed to manage the multidirectional transport of both information and nutrients. An intricate interplay between the nervous, circulatory, and secretory systems is therefore necessary to sustain life, allow delivery of nutrients and therapeutic drugs, and eliminate metabolic waste products and toxins. These systems also provide vulnerable routes for modification by substances of abuse. Addictive substances are, by definition, neurologically active, but as they and their metabolites are spread throughout the body via the nervous, circulatory, respiratory and digestive systems, there is abundant opportunity for interaction with numerous cell and tissue types. Cocaine is one such substance that exerts a broad physiological effect. While a great deal of the research concerning addiction has addressed the neurological effects of cocaine use, only a few studies have been aimed at delineating the role that cocaine plays in various body systems. In this paper, we probe the current research regarding cocaine and the immune system, and map a systems-level view to outline a broader perspective of the biological response to cocaine. Specifically, our overview of the neurological and immunomodulatory effects of the drug will allow a broader perspective of the biological response to cocaine. The focus of this review is on the connection between the nervous and immune systems and the role this connection plays in the long-term complications of cocaine use. By describing the multiplicity of these connections, we hope to inspire detailed investigations into the immunological interplay in cocaine addiction.
© 2014 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Cocaine; addiction; immune system; metabolism; nervous system; signaling

Mesh:

Year:  2014        PMID: 24903164      PMCID: PMC4216763          DOI: 10.1177/1535370214537747

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  100 in total

1.  Cardiovascular complications of cocaine use.

Authors:  R A Lange; L D Hillis
Journal:  N Engl J Med       Date:  2001-08-02       Impact factor: 91.245

Review 2.  Dopamine receptors in the learning, memory and drug reward circuitry.

Authors:  Jeffrey W Dalley; Barry J Everitt
Journal:  Semin Cell Dev Biol       Date:  2009-01-20       Impact factor: 7.727

3.  Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.

Authors:  Kevin J Schneider; Anthony P DeCaprio
Journal:  Chem Res Toxicol       Date:  2013-10-30       Impact factor: 3.739

Review 4.  Molecular mechanisms of drug reinforcement and addiction.

Authors:  D W Self; E J Nestler
Journal:  Annu Rev Neurosci       Date:  1995       Impact factor: 12.449

Review 5.  Molecular diversity of the dopamine receptors.

Authors:  O Civelli; J R Bunzow; D K Grandy
Journal:  Annu Rev Pharmacol Toxicol       Date:  1993       Impact factor: 13.820

6.  CREB-mediated alterations in the amygdala transcriptome: coordinated regulation of immune response genes following cocaine.

Authors:  Laurel E Ecke; Jessica N Cleck; Peter White; Jonathan Schug; Lauren Mifflin; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-08       Impact factor: 5.176

Review 7.  Crack whips the heart: a review of the cardiovascular toxicity of cocaine.

Authors:  Luis Afonso; Tamam Mohammad; Deepak Thatai
Journal:  Am J Cardiol       Date:  2007-08-13       Impact factor: 2.778

Review 8.  The pharmacology of sigma-1 receptors.

Authors:  Tangui Maurice; Tsung-Ping Su
Journal:  Pharmacol Ther       Date:  2009-07-18       Impact factor: 12.310

Review 9.  In vivo effects of cocaine on immune cell function.

Authors:  T Pellegrino; B M Bayer
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

10.  Cocaine infusion increases interferon-gamma and decreases interleukin-10 in cocaine-dependent subjects.

Authors:  X Gan; L Zhang; T Newton; S L Chang; W Ling; V Kermani; O Berger; M C Graves; M Fiala
Journal:  Clin Immunol Immunopathol       Date:  1998-11
View more
  6 in total

1.  Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes.

Authors:  Irma E Cisneros; Mert Erdenizmenli; Kathryn A Cunningham; Slobodan Paessler; Kelly T Dineley
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

2.  Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells.

Authors:  Kalaiselvi Sivalingam; Mayur Doke; Mansoor A Khan; Thangavel Samikkannu
Journal:  Sci Rep       Date:  2021-10-29       Impact factor: 4.379

3.  Cocaine Self-Administration Influences Central Nervous System Immune Responses in Male HIV-1 Transgenic Rats.

Authors:  Chiomah Ezeomah; Chanida Fongsaran; Amanda L Persons; T Celeste Napier; Irma E Cisneros
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

4.  Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease.

Authors:  Elise D Riley; Priscilla Y Hsue; Eric Vittinghoff; Alan H B Wu; Phillip O Coffin; Peter K Moore; Kara L Lynch
Journal:  Drug Alcohol Depend       Date:  2017-01-19       Impact factor: 4.492

Review 5.  Impact of cocaine abuse on HIV pathogenesis.

Authors:  Sabyasachi Dash; Muthukumar Balasubramaniam; Fernando Villalta; Chandravanu Dash; Jui Pandhare
Journal:  Front Microbiol       Date:  2015-10-20       Impact factor: 5.640

6.  Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation.

Authors:  Heather E Soder; Amber M Berumen; Kira E Gomez; Charles E Green; Robert Suchting; Margaret C Wardle; Jessica Vincent; Antonio L Teixeira; Joy M Schmitz; Scott D Lane
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-02-29       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.